NFL Biosciences SA (EPA:ALNFL)
France
· Delayed Price · Currency is EUR 1.028
-0.018 (-1.72%)
Apr 29, 2026, 10:22 AM CET
NFL Biosciences Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | - | 1.91 | 2.34 | 1.05 | 3.04 | Upgrade
|
| Short-Term Investments | - | 0.2 | 0.19 | 0.16 | 0.17 | Upgrade
|
| Cash & Short-Term Investments | - | 2.11 | 2.53 | 1.21 | 3.2 | Upgrade
|
| Cash Growth | - | -16.45% | 108.29% | -62.11% | 933.15% | Upgrade
|
| Other Receivables | - | 1.06 | 1.11 | 0.74 | 0.22 | Upgrade
|
| Receivables | - | 1.06 | 1.11 | 0.74 | 0.22 | Upgrade
|
| Prepaid Expenses | - | 0.17 | 0.18 | 0.3 | 0.13 | Upgrade
|
| Total Current Assets | - | 3.34 | 3.82 | 2.26 | 3.56 | Upgrade
|
| Property, Plant & Equipment | - | 0.12 | 0.01 | 0 | 0 | Upgrade
|
| Long-Term Investments | - | - | - | - | 0 | Upgrade
|
| Other Intangible Assets | - | 0.15 | 0.14 | 0.14 | 0.12 | Upgrade
|
| Other Long-Term Assets | - | -0 | 0 | - | - | Upgrade
|
| Total Assets | - | 3.61 | 3.97 | 2.4 | 3.69 | Upgrade
|
| Accounts Payable | - | 1.15 | 2.16 | 1.19 | 0.12 | Upgrade
|
| Accrued Expenses | - | 0.25 | - | 0.21 | - | Upgrade
|
| Short-Term Debt | - | - | - | 0 | 0 | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.02 | - | - | - | Upgrade
|
| Current Income Taxes Payable | - | - | 0.2 | - | 0.07 | Upgrade
|
| Total Current Liabilities | - | 1.42 | 2.37 | 1.4 | 0.19 | Upgrade
|
| Long-Term Debt | - | 0.02 | 0.06 | 0.08 | 0.09 | Upgrade
|
| Other Long-Term Liabilities | - | 1.19 | 1.19 | 0.07 | 0.13 | Upgrade
|
| Total Liabilities | - | 2.63 | 3.62 | 1.55 | 0.4 | Upgrade
|
| Common Stock | - | 0.29 | 0.24 | 0.16 | 0.16 | Upgrade
|
| Additional Paid-In Capital | - | 2.76 | 7.27 | 4.11 | 4.11 | Upgrade
|
| Retained Earnings | - | -2.08 | -7.17 | -3.42 | -0.98 | Upgrade
|
| Comprehensive Income & Other | - | 0 | - | -0 | - | Upgrade
|
| Shareholders' Equity | - | 0.98 | 0.35 | 0.84 | 3.29 | Upgrade
|
| Total Liabilities & Equity | - | 3.61 | 3.97 | 2.4 | 3.69 | Upgrade
|
| Total Debt | - | 0.04 | 0.06 | 0.08 | 0.09 | Upgrade
|
| Net Cash (Debt) | - | 2.07 | 2.47 | 1.13 | 3.12 | Upgrade
|
| Net Cash Growth | - | -16.00% | 118.12% | -63.74% | 1285.36% | Upgrade
|
| Net Cash Per Share | - | 0.21 | 0.30 | 0.22 | 0.60 | Upgrade
|
| Filing Date Shares Outstanding | - | 9.83 | 8.16 | 5.23 | 5.23 | Upgrade
|
| Total Common Shares Outstanding | - | 9.83 | 8.16 | 5.23 | 5.23 | Upgrade
|
| Working Capital | - | 1.92 | 1.45 | 0.86 | 3.37 | Upgrade
|
| Book Value Per Share | - | 0.10 | 0.04 | 0.16 | 0.63 | Upgrade
|
| Tangible Book Value | - | 0.83 | 0.21 | 0.71 | 3.16 | Upgrade
|
| Tangible Book Value Per Share | - | 0.08 | 0.03 | 0.14 | 0.60 | Upgrade
|
| Machinery | - | 0.18 | 0.05 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.